TAPUR study shows encouraging results for olaparib in BRCA-mutated advanced prostate and pancreatic cancers

The findings were presented as part of the virtual scientific programme of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting.

Please sign in or register for FREE

No comments yet.